NDC 49288-0336

Oyster

Oyster

Oyster is a Intradermal; Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Oyster.

• Product ID: 49288-0336_28463a0e-70af-4169-b592-df65f4f13a5f
• NDC: 49288-0336
• Product Type: Non-standardized Allergenic
• Proprietary Name: Oyster
• Generic Name: Oyster
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1974-03-23
• Marketing Category: BLA / BLA
• Application Number: BLA102223
• Labeler Name: Antigen Laboratories, Inc.
• Substance Name: OYSTER
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Shellfish Proteins [EXT]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 49288-0336-2

5 mL in 1 VIAL, MULTI-DOSE (49288-0336-2)

• Marketing Start Date: 1974-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49288-0336-2 [49288033602]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-29

NDC 49288-0336-4 [49288033604]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-29

NDC 49288-0336-3 [49288033603]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-29

NDC 49288-0336-1 [49288033601]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-29

NDC 49288-0336-5 [49288033605]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-29

Drug Details

Active Ingredients

Ingredient	Strength
OYSTER	.05 g/mL

Pharmacological Class

• Non-Standardized Food Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Dietary Proteins [CS]
• Shellfish Proteins [EXT]

NDC Crossover Matching brand name "Oyster" or generic name "Oyster"

NDC	Brand Name	Generic Name
0268-6189	OYSTER	EASTERN OYSTER
22840-5774	Oyster	Crassostrea virginica
36987-1234	Oyster	Oyster
36987-1235	Oyster	Oyster
36987-1236	Oyster	Oyster
36987-1237	Oyster	Oyster
49288-0336	Oyster	Oyster